Invention Grant
- Patent Title: Heterocyclic nuclear hormone receptor modulators
- Patent Title (中): 杂环核激素受体调节剂
-
Application No.: US14135793Application Date: 2013-12-20
-
Publication No.: US09150592B2Publication Date: 2015-10-06
- Inventor: Kevin P. Cusack , Thomas D. Gordon , Michael Z. Hoemann , David C. Ihle , Bin Li , Gloria Y. Lo Schiavo , Gagandeep K. Somal , Michael Friedman , Martin E. Hayes , Wouter Iwema Bakker
- Applicant: Kevin P. Cusack , Thomas D. Gordon , Michael Z. Hoemann , David C. Ihle , Bin Li , Gloria Y. Lo Schiavo , Gagandeep K. Somal , Michael Friedman , Martin E. Hayes , Wouter Iwema Bakker
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: McCarter & English, LLP
- Agent Elizabeth A. Hanley; Yu Lu
- Priority: WOPCT/CN2013/001505 20131205
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D401/14 ; C07D513/04 ; C07D401/04 ; C07D487/04 ; C07D513/20 ; C07D513/10
Abstract:
The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Public/Granted literature
- US20140179676A1 HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS Public/Granted day:2014-06-26
Information query
